Victory Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$187K Buy
2025
Q2
$188K Buy
2025
Q1
$192K Sell
2024
Q4
$270K Buy
2024
Q3
$181K Buy
2024
Q2
$164K Buy
2024
Q1
$192K Sell
2023
Q4
$202K Buy
2023
Q3
$117K Buy
2023
Q2
$92.1K Sell
2023
Q1
$84.2K Sell
2022
Q4
$102K Buy
2022
Q3
$128K Buy
2021
Q3
Sell
2021
Q2
$242K Buy